Priority Date: 06.09.12 (EP 20120006298)

CHAPERONE-CHAPERONE FUSION POLYPEPTIDES FOR REDUCTION OF INTERFERENCE AND STABILIZATION OF IMMUNOASSAYS

  • Application ID: EP13756904
  • Status: PATENT GRANTED

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
Technology Company
no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Roche Diagnostics GmbH is specialized in C12. Roche Diagnostics GmbH, Roche Diagnostics GmbH is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.09.2012 - Priority Date (EP 20120006298)
  • 13.03.2014 - Publication A1 (WO2014037389)
  • 15.07.2015 - Publication A1 (EP2893021)
  • 24.08.2016 - Publication B1 (EP2893021)

IPC Classification